Capital Stock and Warrants (Details)
|
|
|
|
|
|
|
1 Months Ended |
2 Months Ended |
3 Months Ended |
6 Months Ended |
|
|
|
|
|
|
|
Sep. 11, 2025
USD ($)
|
Sep. 10, 2025
USD ($)
$ / shares
shares
|
Mar. 11, 2025
shares
|
Oct. 11, 2024
USD ($)
$ / shares
$ / item
shares
|
Jun. 21, 2024
USD ($)
|
Mar. 28, 2023
USD ($)
$ / shares
shares
|
Jan. 31, 2025
USD ($)
shares
|
Feb. 28, 2025
USD ($)
shares
|
Jun. 30, 2025
USD ($)
$ / shares
|
Mar. 31, 2025
USD ($)
|
Jun. 30, 2026
USD ($)
Vote
shares
|
Jun. 30, 2025
USD ($)
$ / shares
|
Dec. 31, 2025
shares
|
Feb. 13, 2025
USD ($)
|
Jan. 06, 2025
USD ($)
|
Dec. 31, 2024
USD ($)
$ / shares
|
Dec. 30, 2024
USD ($)
|
Dec. 31, 2023
$ / shares
|
| Capital Stock and Warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Number of common stock voting entitlement per share | Vote |
|
|
|
|
|
|
|
|
|
|
1
|
|
|
|
|
|
|
|
| Common stock, shares issued (in shares) |
|
|
|
|
|
|
|
|
|
|
5,527,071
|
|
2,200,240
|
|
|
|
|
|
| Common stock outstanding description |
|
|
|
|
|
|
|
|
|
|
The Company’s outstanding shares of common stock may occasionally include shares that are deemed delivered under U.S. GAAP. Shares that are deemed delivered currently include shares that have vested, but have not yet been delivered, under tax-deferred equity awards. There are no voting rights for shares that are deemed delivered under U.S. GAAP until the actual delivery of shares takes place. There are currently 200,000,000 shares of common stock authorized for issuance.
|
|
|
|
|
|
|
|
| Common stock, shares authorized (in shares) |
|
|
|
|
|
|
|
|
|
|
200,000,000
|
|
200,000,000
|
|
|
|
|
|
| Expenses from abandoned financing transaction | $ |
|
|
|
|
|
|
|
|
$ 5,000
|
|
|
$ 661,000
|
|
|
|
|
|
|
| Common stock, shares outstanding (in shares) |
|
|
|
|
|
|
|
|
|
|
5,527,071
|
|
2,200,240
|
|
|
|
|
|
| 2023 Offering |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Capital Stock and Warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Common stock, shares issued (in shares) |
|
|
|
|
|
13,750
|
|
|
|
|
|
|
|
|
|
|
|
|
| Securities reserved for issuance | $ |
|
|
|
|
|
$ 2,700,000
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrants exercisable term |
|
|
|
|
|
6 years
|
|
|
|
|
|
|
|
|
|
|
|
|
| Exercise price (in dollars per share) | $ / shares |
|
|
|
|
|
$ 240
|
|
|
|
|
|
|
|
|
|
|
|
|
| 2023 Offering | Warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Capital Stock and Warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Exercise price (in dollars per share) | $ / shares |
|
|
|
|
|
|
|
|
$ 8.4
|
|
|
$ 8.4
|
|
|
|
$ 9
|
|
$ 49.8
|
| December 2024 Prospectus Supplement |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Capital Stock and Warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Common stock available for sale | $ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 7,460,000
|
|
| Stock issued during period |
|
|
|
|
|
|
209,348
|
|
|
|
|
|
|
|
|
|
|
|
| Proceeds of securities offerings | $ |
|
|
|
|
|
|
$ 7,000,000
|
|
|
|
|
|
|
|
|
|
|
|
| Issuance costs | $ |
|
|
|
|
|
|
$ 400,000
|
|
|
|
|
|
|
|
|
|
|
|
| January 2025 Prospectus Supplement |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Capital Stock and Warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Common stock available for sale | $ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 6,600,000
|
|
|
|
| Stock issued during period |
|
|
|
|
|
|
|
343,465
|
|
|
|
|
|
|
|
|
|
|
| Proceeds of securities offerings | $ |
|
|
|
|
|
|
|
$ 6,300,000
|
|
|
|
|
|
|
|
|
|
|
| Issuance costs | $ |
|
|
|
|
|
|
|
$ 300,000
|
|
|
|
|
|
|
|
|
|
|
| February 2025 Prospectus Supplement |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Capital Stock and Warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Common stock available for sale | $ |
|
|
|
|
|
|
|
|
|
|
$ 31,700,000
|
|
|
$ 80,000,000
|
|
|
|
|
| Stock issued during period |
|
|
|
|
|
|
|
|
|
|
3,299,728
|
|
|
|
|
|
|
|
| Proceeds of securities offerings | $ |
|
|
|
|
|
|
|
|
|
|
$ 31,800,000
|
|
|
|
|
|
|
|
| Issuance costs | $ |
|
|
|
|
|
|
|
|
|
|
$ 1,100,000
|
|
|
|
|
|
|
|
| 2025 Offering |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Capital Stock and Warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Common stock, shares issued (in shares) |
|
120,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Class of warrant or right, number of securities called by warrants or rights |
|
465,347
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrants exercisable term |
|
5 years
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Exercise price (in dollars per share) | $ / shares |
|
$ 7.79
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Net proceeds from a sale of common stock and warrant issuance | $ |
$ 4,000,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Regulation A offering |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Capital Stock and Warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maximum offering units |
|
|
0
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Additional offering expense | $ |
|
|
|
|
|
|
|
|
|
$ 400,000
|
|
|
|
|
|
|
|
|
| Prepaid financing expense | $ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 300,000
|
|
|
| Expenses from abandoned financing transaction | $ |
|
|
|
|
|
|
|
|
|
|
|
$ 700,000
|
|
|
|
|
|
|
| Pre Funded Warrant | 2025 Offering |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Capital Stock and Warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Exercise price (in dollars per share) | $ / shares |
|
$ 0.00001
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrants outstanding |
|
|
|
|
|
|
|
|
|
|
0
|
|
|
|
|
|
|
|
| Common Stock Or Pre Funded Warrant | 2025 Offering |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Capital Stock and Warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Class of warrant or right, number of securities called by warrants or rights |
|
585,347
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maximum | 2023 Offering |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Capital Stock and Warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Class of warrant or right, number of securities called by warrants or rights |
|
|
|
|
|
13,750
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maximum | At The Market Program |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Capital Stock and Warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Securities sold under agreements | $ |
|
|
|
|
$ 3,400,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maximum | February 2025 Prospectus Supplement |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Capital Stock and Warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Common stock available for sale | $ |
|
$ 70,000,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maximum | Regulation A offering |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Capital Stock and Warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maximum offering units |
|
|
|
166,667
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maximum | Pre Funded Warrant | 2025 Offering |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Capital Stock and Warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Stock price | $ / shares |
|
$ 7.92
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Pre Funded Warrant | 2025 Offering |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Capital Stock and Warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrants outstanding |
|
|
|
|
|
|
|
|
|
|
585,347
|
|
|
|
|
|
|
|
| Registered Direct Offering Placement Agent Warrants | 2025 Offering |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Capital Stock and Warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Exercise price (in dollars per share) | $ / shares |
|
$ 9.9
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrants outstanding |
|
|
|
|
|
|
|
|
|
|
18,848
|
|
|
|
|
|
|
|
| Registered Direct Offering Placement Agent Warrants | Maximum | 2025 Offering |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Capital Stock and Warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Class of warrant or right, number of securities called by warrants or rights |
|
40,974
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrants 2023 and 2024 | 2025 Offering |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Capital Stock and Warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Class of warrant or right, number of securities called by warrants or rights |
|
47,764
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Aggregate gross proceeds | $ |
|
$ 400,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 2023 Warrants | 2025 Offering |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Capital Stock and Warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Exercise price (in dollars per share) | $ / shares |
|
$ 6.7595
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrants exercise price | $ / shares |
|
6.8845
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 2024 Warrants | 2025 Offering |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Capital Stock and Warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Exercise price (in dollars per share) | $ / shares |
|
55.2
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrants exercise price | $ / shares |
|
7.92
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| New Warrants | 2025 Offering |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Capital Stock and Warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Exercise price (in dollars per share) | $ / shares |
|
$ 7.79
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrants and rights outstanding measurement input term |
|
5 years
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| New Warrants | Maximum | 2025 Offering |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Capital Stock and Warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Class of warrant or right, number of securities called by warrants or rights |
|
47,764
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Placement Agent Warrants | 2025 Offering |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Capital Stock and Warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Exercise price (in dollars per share) | $ / shares |
|
$ 9.9
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrants outstanding |
|
|
|
|
|
|
|
|
|
|
1,538
|
|
|
|
|
|
|
|
| Each warrant of exercisable |
|
1
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Placement Agent Warrants | Maximum | 2025 Offering |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Capital Stock and Warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Class of warrant or right, number of securities called by warrants or rights |
|
3,343
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Series A Convertible Preferred Stock | Regulation A offering |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Capital Stock and Warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Shares issue per unit |
|
|
|
1
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subordinated Business Loan Agreement |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Capital Stock and Warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Offering price | $ / item |
|
|
|
45
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subordinated Business Loan Agreement | Warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Capital Stock and Warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Stock purchase warrants |
|
|
|
3
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subordinated Business Loan Agreement | Maximum |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Capital Stock and Warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maximum offering amount | $ |
|
|
|
$ 7,500,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subordinated Business Loan Agreement | Series A Convertible Preferred Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Capital Stock and Warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Stock issued during period |
|
|
|
166,667
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Convertible preferred stock |
|
|
|
333,333
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Common Stock, Exercise Price of $45.00 Per Share | Subordinated Business Loan Agreement |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Capital Stock and Warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Class of warrant or right, number of securities called by warrants or rights |
|
|
|
333,333
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Each warrant of exercisable |
|
|
|
1
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Number of warrants to purchase |
|
|
|
2
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Aggregate purchase price per share | $ / shares |
|
|
|
$ 45
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Common Stock, Exercise Price of $60.00 Per Shar | Subordinated Business Loan Agreement |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Capital Stock and Warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Class of warrant or right, number of securities called by warrants or rights |
|
|
|
166,667
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Each warrant of exercisable |
|
|
|
1
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Number of warrants to purchase |
|
|
|
1
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Aggregate purchase price per share | $ / shares |
|
|
|
$ 60
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|